Hrt Financial LP Alkermes Plc. Transaction History

Hrt Financial LP

$20.6 Billion
Q3 2025

A detailed history of Hrt Financial LP transactions in Alkermes Plc. stock. As of the latest transaction made, Hrt Financial LP holds 18,277 shares of ALKS stock, worth $530,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,277

Holding current value

$530,764

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$26.13 - $30.46 $477,578 - $556,717	18,277 New	18,277 $548,000
Q1 2025 May 15, 2025	BUY	$28.08 - $36.0 $628,037 - $805,176	22,366 Added 22.31%	122,638 $4.05 Million
Q4 2024 Feb 14, 2025	SELL	$25.7 - $31.46 $5.5 Million - $6.74 Million	-214,171 Reduced 68.11%	100,272 $2.88 Million
Q3 2024 Nov 12, 2024	BUY	$23.01 - $28.55 $7.24 Million - $8.98 Million	314,443 New	314,443 $8.8 Million
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $1.64 Million - $1.92 Million	60,196 New	60,196 $1.69 Million

Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $750,314 - $860,297	29,645 New	29,645 $835,000
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $474,298 - $687,085	21,559 Added 82.96%	47,546 $1.06 Million
Q2 2022 Aug 12, 2022	SELL	$26.4 - $30.54 $227,092 - $262,705	-8,602 Reduced 24.87%	25,987 $774,000
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $797,968 - $968,146	34,589 New	34,589 $910,000
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $2.47 Million - $3.31 Million	-131,418 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $1.53 Million - $1.95 Million	83,935 Added 176.77%	131,418 $2.45 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $490,371 - $704,172	31,863 Added 203.99%	47,483 $947,000
Q3 2020 Nov 13, 2020	SELL	$16.16 - $20.66 $97,428 - $124,559	-6,029 Reduced 27.85%	15,620 $258,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $19.41 $288,148 - $420,207	21,649 New	21,649 $420,000
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $2.45 Million - $3.98 Million	-187,364 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $2.64 Million - $3.32 Million	152,797 Added 442.03%	187,364 $3.82 Million
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $674,402 - $839,286	34,567 New	34,567 $674,000

Others Institutions Holding ALKS

# of Institutions

401

Shares Held

176M

Call Options Held

901K

Put Options Held

400K

Black Rock Inc. New York, NY

29.1M
Shares

$845 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

18.2M
Shares

$528 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

10.2M
Shares

$297 Million
0.03% of portfolio
State Street Corp Boston, MA

8.54M
Shares

$248 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

8.09M
Shares

$235 Million
1.98% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.77B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account